Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Assessing signal loss in maternal heart rate monitoring during labor

Official title: Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

Run by University Hospital, Strasbourg, France · NCT06906744 · Data updated 2026-11-12

This study looks at how often and why heart rate monitors lose signal during labor to see how it affects babies and the need for extra medical help.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment500 (estimated)
SponsorUniversity Hospital, Strasbourg, France
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedFebruary 22, 2024
Main results expectedDecember 22, 2025
Study endsDecember 22, 2025
Registry record updatedApril 2, 2025
Trial IDNCT06906744 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult females aged 18 and older who are in labor and have a gestational age greater than 36 weeks.

Probably not a fit

Patients who have not undergone cardiotocography or those with a gestational age of less than 36 weeks may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on the frequency and causes of signal loss in cardiotocography (CTG) recordings, which are crucial for monitoring fetal well-being during labor. It aims to gather updated data on the impact of signal loss on neonatal morbidity and unnecessary obstetric interventions, addressing a gap in knowledge that has persisted for over a decade. The study will involve adult females who have undergone CTG in the labor and delivery room at a specific hospital during a defined time period.

Why it matters

Potential benefit: If successful, this study could lead to improved monitoring techniques that enhance fetal well-being and reduce unnecessary medical interventions.

How similar studies have gone: While there is limited recent data on this specific issue, previous studies have highlighted the importance of accurate CTG monitoring, suggesting that addressing signal loss could be a significant advancement.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult female (≥ 18 years old)
* Patient treated at a hospital between February 1, 2024 and February 28, 2024
* Having undergone cardiotocography in the labor and delivery room
* Gestational age at delivery \>36 weeks

Exclusion Criteria:

* Patient who has expressed opposition to the use of medical record data
* Patient without CTG
* Gestational age at delivery \<36 weeks

Where it's running

  • Service de Gynécologie-Obstétrique CMCO - CHU de Strasbourg - France
    Strasbourg, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.